Development of target therapy against chemoresistant triple-negative breast cancer

○Tatsuya Fujikawa, Fumihiro Sanada, Yoshiaki Taniyama, Kana Shibata, Naruto Katsuragi, Nobutaka Koibuchi, Ryoko Nakagawa, Hiromi Rakugi, Ryuichi Morishita

[3P-0356] Development of target therapy against chemoresistant triple-negative breast cancer

○Tatsuya Fujikawa¹, Fumihiro Sanada¹, Yoshiaki Taniyama¹, Kana Shibata¹, Naruto Katsuragi¹, Nobutaka Koibuchi¹, Ryoko Nakagawa¹, Hiromi Rakugi², Ryuichi Morishita¹ (1.Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, 2.Geriatric and General Medicine, Osaka University Graduate School of Medicine)

periostin, triple-negative breast cancer, chemoresistance

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 43rd Annual Meeting of the Molecular Biology Society of Japan

[3P-0356] Development of target therapy against chemoresistant triple-negative breast cancer

Password